What is the latest NEPHROCARE stock price?
The latest stored price for NEPHROCARE is Rs 93.75 as of 2026-09-18.
gimli
NEPHROCARE stock AI analysis
NEPHROCARE Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
NEPHRO CARE INDIA LIMITED is a small-cap stock in Unclassified. This Gimli page shows the latest available NEPHROCARE price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹93.75
1W return
+2.52%
1M return
+18.82%
3M return
+35.87%
6M return
+41.83%
1Y return
-36.83%
Market cap
₹n/a
PE
n/a
PB
n/a
ROE
+6.11%
ROCE
n/a
RSI
55.56
Turnover
₹0.13 cr
Why it can matter in screens
- Momentum: NEPHROCARE is above 50DMA, above 200DMA; RSI is 55.56.
- Returns: 1D +2.29%, 1W +2.52%, 1M +18.82%, 3M +35.87%, 1Y -36.83%.
- Trend levels: 52W high ₹156.35, 52W low ₹50.05, off high -40.04%.
- Liquidity: latest turnover is ₹0.13 cr; volume vs 20D is +0.36%.
- Valuation/profitability: PE n/a, PB n/a, ROE +6.11%, ROCE n/a.
- Growth: 3Y sales CAGR +70.48%, 3Y profit CAGR +20.21%.
Quick Answers
Is NEPHROCARE above its 50DMA and 200DMA?
NEPHROCARE is above 50DMA, above 200DMA. The latest 50DMA is 80.50 and the latest 200DMA is 85.99.
What are NEPHROCARE PE, ROE and ROCE?
NEPHROCARE has PE n/a, ROE +6.11%, and ROCE n/a in Gimli's latest available snapshot.
How has NEPHROCARE performed recently?
NEPHROCARE has returned +18.82% over 1 month, +35.87% over 3 months, and -36.83% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 20.75 cr | 2.85 cr | 1.00 cr | 0.61 |
| 2025-12-31 | 22.66 cr | 2.00 cr | 0.42 cr | 0.26 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 84.71 cr | 10.67 cr | 3.37 cr | nan |
| 2025-03-31 | 46.03 cr | 7.30 cr | 3.64 cr | 2.38 |
| 2024-03-31 | 27.23 cr | 6.75 cr | 4.41 cr | 2.68 |
| 2023-03-31 | 17.09 cr | 3.59 cr | 1.94 cr | 1.18 |
| 2022-03-31 | n/a | n/a | n/a | -0.01 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 72.72 cr | 6.49 cr | n/a | 56.90 cr |
| 2025-03-31 | 68.28 cr | 4.66 cr | n/a | 53.48 cr |
| 2024-03-31 | 20.97 cr | 1.29 cr | n/a | 15.03 cr |
| 2023-03-31 | 8.31 cr | 2.32 cr | 2.46 cr | 2.44 cr |
| 2022-03-31 | n/a | n/a | 2.54 cr | n/a |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 2.21 cr | -5.60 cr | n/a |
| 2025-03-31 | 7.82 cr | -21.98 cr | n/a |
| 2024-03-31 | 0.91 cr | -2.38 cr | n/a |
| 2023-03-31 | 4.31 cr | 3.76 cr | n/a |
| 2022-03-31 | n/a | n/a | n/a |
Shareholding Trend
No recent data available.
Industry Peers
No recent data available.
Try these prompts
- Analyze NEPHRO CARE INDIA with valuation, momentum and industry peers
- Compare NEPHROCARE with other Unclassified stocks
- Show small-cap stocks in Unclassified above 50DMA with positive 1M return
- Find Unclassified stocks with improving momentum and reasonable valuation
Related screen ideas
- View Unclassified stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare NEPHROCARE with other Unclassified stocks
Data snapshot: 2026-09-18. Not investment advice.